Cargando…
Targeting β‐cell functions in therapy for type 2 diabetes
Recently, Leahy et al. issued a “consensus statement” in regard to targeting β‐cell function in therapy for type 2 diabetes that recommends continued multidisciplinary efforts to realign treatment of type 2 diabetes to preserve β‐cell function by early intervention. This might be applicable not only...
Autores principales: | Fujimoto, Shimpei, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014915/ https://www.ncbi.nlm.nih.gov/pubmed/24843480 http://dx.doi.org/10.1111/j.2040-1124.2011.00117.x |
Ejemplares similares
-
Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells
por: Mukai, Eri, et al.
Publicado: (2022) -
Control of intestinal stem cell fate: A novel approach to treating diabetes
por: Yamane, Shunsuke, et al.
Publicado: (2015) -
Long‐term effect of dipeptidyl peptidase‐4 inhibition on β‐cell mass in an advanced‐aged diet‐induced obesity mouse model
por: Yamane, Shunsuke, et al.
Publicado: (2014) -
Current understanding of imeglimin action on pancreatic β‐cells: Involvement of mitochondria and endoplasmic reticulum homeostasis
por: Fauzi, Muhammad, et al.
Publicado: (2022) -
Circadian rhythms and diabetes
por: Kurose, Takeshi, et al.
Publicado: (2011)